SCHEMBL4641875

SCHEMBL4641875

Cc1cc2cc3ccccc3nc2cc1C

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.65
HPGD P15428 3/20 0.65
MAPT P10636 3/20 0.65
GLA P06280 2/20 0.65
ACHE P22303 1/20 0.65
NQO2 P16083 4/20 0.64
PDE10A Q9Y233 1/20 0.60
TDP1 Q9NUW8 1/20 0.59
HTR3A P46098 1/20 0.53
MBNL1 Q9NR56 1/20 0.53
KDM4E B2RXH2 3/20 0.48
GAA P10253 2/20 0.48
STAT3 P40763 1/20 0.48
TERT O14746 1/20 0.48
CYP1A2 P05177 3/20 0.45
NPC1 O15118 4/20 0.42
RAB9A P51151 3/20 0.42
LMNA P02545 2/20 0.42
POLB P06746 2/20 0.42
KMT2A Q03164 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29660632 1.00 ALDH1A1 (0.65) ALDH1A1HPGDMAPTGLAACHE
SCHEMBL11702475 0.84 TERT (0.74) ALDH1A1HPGDMAPTGLAACHE
SCHEMBL29379154 0.84 MAPT (0.83) ALDH1A1HPGDMAPTGLAACHE
SCHEMBL13156489 0.84 MAPT (0.83) ALDH1A1HPGDMAPTGLAACHE
SCHEMBL13156486 0.84 MAPT (0.83) ALDH1A1HPGDMAPTGLAACHE
SCHEMBL9755344 0.83 TERT (0.64) ALDH1A1MAPTNQO2PDE10ATDP1
Acridine SCHEMBL28194753 0.83 ALDH1A1 (0.65) ALDH1A1HPGDMAPTGLAACHE
SCHEMBL22326435 0.82 PDE10A (0.77) ALDH1A1HPGDMAPTGLAACHE
SCHEMBL913147 0.81 ALDH1A1 (0.79) ALDH1A1HPGDMAPTGLAACHE
Acridine SCHEMBL8339 0.81 ALDH1A1 (1.00) ALDH1A1HPGDMAPTGLAACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110114376-B Curable composition, method for producing cured product, cured product thereof, and adhesive using same 株式会社ADEKA 2022-06-14 CN disclosed
EP-3339331-B1 COMPOSITION ADEKA CORP (JP) 2022-02-16 EP disclosed
CN-108419438-B Coloring composition 株式会社艾迪科 2021-10-01 CN disclosed
CN-112154167-A Composition, cured product, optical filter, and method for producing cured product 株式会社艾迪科 2020-12-29 CN disclosed
CN-111566173-A Coating composition, method for curing the composition, barrier film, and method for producing cured product 株式会社艾迪科 2020-08-21 CN disclosed
WO-2020021969-A1 COMPOSITION, CURED PRODUCT, OPTICAL FILTER, AND PRODUCTION METHOD FOR CURED PRODUCT 株式会社ADEKA 2020-01-30 WO disclosed
EP-2518111-B1 COMPOSITION AND LUMINESCENT ELEMENT OBTAINED USING SAME SUMITOMO CHEMICAL CO (JP) 2019-03-13 EP disclosed
EP-3339331-A1 COMPOSITION Adeka Corporation (JP) 2018-06-27 EP disclosed
US-9780308-B2 Composition and light emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-03 US disclosed
US-9780308-B2 Composition and light emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-10-03 US disclosed
US-20110127517-A1 COMPOUND CONTAINING 1,3-DIENE STRUCTURE AND METHOD FOR PRODUCING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-06-02 US disclosed
US-20110127517-A1 COMPOUND CONTAINING 1,3-DIENE STRUCTURE AND METHOD FOR PRODUCING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-06-02 US disclosed
EP-2308910-A1 POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME Sumitomo Chemical Company, Limited (JP) 2011-04-13 EP disclosed
US-20100081758-A1 PIGMENT DISPERSION AND INK COMPOSITION USING THE SAME FUJIFILM CORPORATION (JP) 2010-04-01 US disclosed
US-7662478-B2 Polymer and polymer light-emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-02-16 US disclosed
US-20080166317-A1 Modified Polyamines BASF AKTIENGESELLSCHAFT (DE) 2008-07-10 US disclosed
US-20080103278-A1 NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED 2008-05-01 US disclosed
EP-1883642-A1 MODIFIED POLYAMINES BASF AKTIENGESELLSCHAFT (DE) 2008-02-06 EP disclosed
WO-2006120185-A1 MODIFIED POLYAMINES BASF AKTIENGESELLSCHAFT (DE) 2006-11-16 WO disclosed
WO-1991005770-A1 POTENTIAL ANTICANCER AGENTS DERIVED FROM ACRIDINE SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1991-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080103278-A1 NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME CRY1, ARCN1, CORO1A ALDH1A1 272/4885HPGD 3188/4885MAPT 2640/4885
US-20110127517-A1 COMPOUND CONTAINING 1,3-DIENE STRUCTURE AND METHOD FOR PRODUCING SAME KCNMA1, KCNA1, KCNJ11 ALDH1A1 532/4885HPGD 3238/4885MAPT 4472/4885
US-20080166317-A1 Modified Polyamines SRM, PRMT5, H1-5 ALDH1A1 3217/4885HPGD 4563/4885MAPT 3552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.